December 2, 2021
Amzell B.V. (Amzell), a specialist development pharmaceutical company, and Amring Pharmaceuticals Inc. (Amring), a niche generics and value-driven brand company, announced today that they will be in attendance at the 2021 American Epilepsy Society (AES) Annual Meeting in Chicago.
Recent Comments